Inactive and active state structures template selective tools for the human 5-HT5A receptor

Shicheng Zhang; He Chen; Chengwei Zhang; Ying Yang; Petr Popov; Jing Liu; Brian E. Krumm; Can Cao; Kuglae Kim; Yan Xiong; Vsevolod Katritch; Brian K. Shoichet; Jian Jin; Jonathan F. Fay; Bryan L. Roth

doi:10.1038/s41594-022-00796-6

Inactive and active state structures template selective tools for the human 5-HT_5A receptor

Shicheng Zhang, He Chen, Chengwei Zhang, Ying Yang, Petr Popov, Jing Liu, Brian E. Krumm, Can Cao, Kuglae Kim, Yan Xiong, Vsevolod Katritch, Brian K. Shoichet, Jian Jin, Jonathan F. Fay, Bryan L. Roth

Department of Pharmacy

Research output: Contribution to journal › Article › peer-review

5 Citations (Scopus)

Abstract

Serotonin receptors are important targets for established therapeutics and drug development as they are expressed throughout the human body and play key roles in cell signaling. There are 12 serotonergic G protein-coupled receptor members encoded in the human genome, of which the 5-hydroxytryptamine (5-HT)_5A receptor (5-HT_5AR) is the least understood and lacks selective tool compounds. Here, we report four high-resolution (2.73–2.80 Å) structures of human 5-HT_5ARs, including an inactive state structure bound to an antagonist AS2674723 by crystallization and active state structures bound to a partial agonist lisuride and two full agonists, 5-carboxamidotryptamine (5-CT) and methylergometrine, by cryo-EM. Leveraging the new structures, we developed a highly selective and potent antagonist for 5-HT_5AR. Collectively, these findings both enhance our understanding of this enigmatic receptor and provide a roadmap for structure-based drug discovery for 5-HT_5AR.

Original language	English
Pages (from-to)	677-687
Number of pages	11
Journal	Nature Structural and Molecular Biology
Volume	29
Issue number	7
DOIs	https://doi.org/10.1038/s41594-022-00796-6
Publication status	Published - 2022 Jul

Bibliographical note

Funding Information:
This work was supported by US National Institutes of Health grants RO1MH112205 and U24DK1169195 (to B.L.R.) and by R35GM122481 (to B.K.S.). This work also used the NMR spectrometer systems at Mount Sinai, acquired with funding from National Institutes of Health SIG grants 1S10OD025132 and 1S10OD028504 (to J.J.). We gratefully acknowledge M.J. Miley and the UNC macromolecular crystallization core for the use of their equipment for crystal collection and transport along with the UNC Flow Cytometry Core Facility. Both facilities are supported in part by a P30 CA016086 Cancer Center Core Support Grant to the UNC Lineberger Comprehensive Cancer Center. We also thank the staff of GM/CA@APS, which has been funded with federal funds from the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006). This research used resources of the Advanced Photon Source, a US Department of Energy Office of Science User Facility operated for the Department of Energy Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357. We thank J. Peck and J. Strauss of the UNC CryoEM Core Facility for their excellent technical assistance with this project. We are grateful to Schrödinger for the academic grant of FEP+ and multiple other tools in their software suite. The Titan X Pascal used for this research was kindly donated to J.F.F. by Nvidia.

Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer Nature America, Inc.

All Science Journal Classification (ASJC) codes

Structural Biology
Molecular Biology

Access to Document

10.1038/s41594-022-00796-6

Cite this

Zhang, S., Chen, H., Zhang, C., Yang, Y., Popov, P., Liu, J., Krumm, B. E., Cao, C., Kim, K., Xiong, Y., Katritch, V., Shoichet, B. K., Jin, J., Fay, J. F., & Roth, B. L. (2022). Inactive and active state structures template selective tools for the human 5-HT_5A receptor. Nature Structural and Molecular Biology, 29(7), 677-687. https://doi.org/10.1038/s41594-022-00796-6

@article{1b91217c3c184e87bc46bb8cbf642058,

title = "Inactive and active state structures template selective tools for the human 5-HT5A receptor",

abstract = "Serotonin receptors are important targets for established therapeutics and drug development as they are expressed throughout the human body and play key roles in cell signaling. There are 12 serotonergic G protein-coupled receptor members encoded in the human genome, of which the 5-hydroxytryptamine (5-HT)5A receptor (5-HT5AR) is the least understood and lacks selective tool compounds. Here, we report four high-resolution (2.73–2.80 {\AA}) structures of human 5-HT5ARs, including an inactive state structure bound to an antagonist AS2674723 by crystallization and active state structures bound to a partial agonist lisuride and two full agonists, 5-carboxamidotryptamine (5-CT) and methylergometrine, by cryo-EM. Leveraging the new structures, we developed a highly selective and potent antagonist for 5-HT5AR. Collectively, these findings both enhance our understanding of this enigmatic receptor and provide a roadmap for structure-based drug discovery for 5-HT5AR.",

author = "Shicheng Zhang and He Chen and Chengwei Zhang and Ying Yang and Petr Popov and Jing Liu and Krumm, {Brian E.} and Can Cao and Kuglae Kim and Yan Xiong and Vsevolod Katritch and Shoichet, {Brian K.} and Jian Jin and Fay, {Jonathan F.} and Roth, {Bryan L.}",

note = "Funding Information: This work was supported by US National Institutes of Health grants RO1MH112205 and U24DK1169195 (to B.L.R.) and by R35GM122481 (to B.K.S.). This work also used the NMR spectrometer systems at Mount Sinai, acquired with funding from National Institutes of Health SIG grants 1S10OD025132 and 1S10OD028504 (to J.J.). We gratefully acknowledge M.J. Miley and the UNC macromolecular crystallization core for the use of their equipment for crystal collection and transport along with the UNC Flow Cytometry Core Facility. Both facilities are supported in part by a P30 CA016086 Cancer Center Core Support Grant to the UNC Lineberger Comprehensive Cancer Center. We also thank the staff of GM/CA@APS, which has been funded with federal funds from the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006). This research used resources of the Advanced Photon Source, a US Department of Energy Office of Science User Facility operated for the Department of Energy Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357. We thank J. Peck and J. Strauss of the UNC CryoEM Core Facility for their excellent technical assistance with this project. We are grateful to Schr{\"o}dinger for the academic grant of FEP+ and multiple other tools in their software suite. The Titan X Pascal used for this research was kindly donated to J.F.F. by Nvidia. Publisher Copyright: {\textcopyright} 2022, The Author(s), under exclusive licence to Springer Nature America, Inc.",

year = "2022",

month = jul,

doi = "10.1038/s41594-022-00796-6",

language = "English",

volume = "29",

pages = "677--687",

journal = "Nature Structural Biology",

issn = "1545-9993",

publisher = "Nature Publishing Group",

number = "7",

}

TY - JOUR

T1 - Inactive and active state structures template selective tools for the human 5-HT5A receptor

AU - Zhang, Shicheng

AU - Chen, He

AU - Zhang, Chengwei

AU - Yang, Ying

AU - Popov, Petr

AU - Liu, Jing

AU - Krumm, Brian E.

AU - Cao, Can

AU - Kim, Kuglae

AU - Xiong, Yan

AU - Katritch, Vsevolod

AU - Shoichet, Brian K.

AU - Jin, Jian

AU - Fay, Jonathan F.

AU - Roth, Bryan L.

N1 - Funding Information: This work was supported by US National Institutes of Health grants RO1MH112205 and U24DK1169195 (to B.L.R.) and by R35GM122481 (to B.K.S.). This work also used the NMR spectrometer systems at Mount Sinai, acquired with funding from National Institutes of Health SIG grants 1S10OD025132 and 1S10OD028504 (to J.J.). We gratefully acknowledge M.J. Miley and the UNC macromolecular crystallization core for the use of their equipment for crystal collection and transport along with the UNC Flow Cytometry Core Facility. Both facilities are supported in part by a P30 CA016086 Cancer Center Core Support Grant to the UNC Lineberger Comprehensive Cancer Center. We also thank the staff of GM/CA@APS, which has been funded with federal funds from the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006). This research used resources of the Advanced Photon Source, a US Department of Energy Office of Science User Facility operated for the Department of Energy Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357. We thank J. Peck and J. Strauss of the UNC CryoEM Core Facility for their excellent technical assistance with this project. We are grateful to Schrödinger for the academic grant of FEP+ and multiple other tools in their software suite. The Titan X Pascal used for this research was kindly donated to J.F.F. by Nvidia. Publisher Copyright: © 2022, The Author(s), under exclusive licence to Springer Nature America, Inc.

PY - 2022/7

Y1 - 2022/7

N2 - Serotonin receptors are important targets for established therapeutics and drug development as they are expressed throughout the human body and play key roles in cell signaling. There are 12 serotonergic G protein-coupled receptor members encoded in the human genome, of which the 5-hydroxytryptamine (5-HT)5A receptor (5-HT5AR) is the least understood and lacks selective tool compounds. Here, we report four high-resolution (2.73–2.80 Å) structures of human 5-HT5ARs, including an inactive state structure bound to an antagonist AS2674723 by crystallization and active state structures bound to a partial agonist lisuride and two full agonists, 5-carboxamidotryptamine (5-CT) and methylergometrine, by cryo-EM. Leveraging the new structures, we developed a highly selective and potent antagonist for 5-HT5AR. Collectively, these findings both enhance our understanding of this enigmatic receptor and provide a roadmap for structure-based drug discovery for 5-HT5AR.

AB - Serotonin receptors are important targets for established therapeutics and drug development as they are expressed throughout the human body and play key roles in cell signaling. There are 12 serotonergic G protein-coupled receptor members encoded in the human genome, of which the 5-hydroxytryptamine (5-HT)5A receptor (5-HT5AR) is the least understood and lacks selective tool compounds. Here, we report four high-resolution (2.73–2.80 Å) structures of human 5-HT5ARs, including an inactive state structure bound to an antagonist AS2674723 by crystallization and active state structures bound to a partial agonist lisuride and two full agonists, 5-carboxamidotryptamine (5-CT) and methylergometrine, by cryo-EM. Leveraging the new structures, we developed a highly selective and potent antagonist for 5-HT5AR. Collectively, these findings both enhance our understanding of this enigmatic receptor and provide a roadmap for structure-based drug discovery for 5-HT5AR.

UR - http://www.scopus.com/inward/record.url?scp=85134162144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85134162144&partnerID=8YFLogxK

U2 - 10.1038/s41594-022-00796-6

DO - 10.1038/s41594-022-00796-6

M3 - Article

C2 - 35835867

AN - SCOPUS:85134162144

SN - 1545-9993

VL - 29

SP - 677

EP - 687

JO - Nature Structural Biology

JF - Nature Structural Biology

IS - 7

ER -